Mainz Biomed and Dante Genomics Announce Full Commercial Availability of ColoAlert in Italy and the United Arab Emirates

- ColoAlert to be marketed through Dante's extensive database and sold via its region-specific, ecommerce websites -BERKELEY, Calif. and MAINZ, Germany and NEW YORK, Aug. 16, 2022, a global leader in genomics

Related Keywords

Germany ,Italy ,Berkeley ,California ,United States ,Dubai ,Dubayy ,United Arab Emirates ,Americans ,American ,Andrea Riposati ,Laura Dangelo ,Mainz Biomed ,Guido Baechler ,Exchange Commission ,Europe Union ,American Cancer Society ,Chief Executive Officer ,Real Time Polymerase Chain Reaction Based ,Private Securities Litigation Reform Act ,Genomics Contact ,Mainz ,Abiomed ,Ante ,Genomics ,Nnounce ,Bull ,Commercial ,Availability ,Coloalert ,United ,Rab ,Emirates ,